ERBB2 and breast cancer: The natural course of BC varies depending on subtype, where the Luminal-like tumours have a slow but steady rate of recurrence and death over the years, while the HER2+ and TNBC have a higher mortality rate initially, which declines after the first 5 years [24, 25].